GenVec Inc (fka GNVC)

[Teliz2009]

National Veterinary Stockpile by November 2009

Received pre-licensing from USDA Center for Veterinary Biologics for the first ever next-generation molecular vaccine for Foot and Mouth Disease virus to significantly improve the Nation’s ability to prevent, protect and mitigate the effects of an outbreak of FMD. The Foreign Animal Disease vaccines and diagnostics program is on schedule to have the vaccine fully licensed and ready for production by private industry and procurement to the National Veterinary Stockpile by November 2009. Technology used in the next-generation DIVA vaccine will also accelerate the speed at which new vaccines can be produced.

http://www.dhs.gov/ynews/testimony/testimony_1238089175289.shtm